NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Maximum Oxygen Uptake During Long-Duration Space Flight: Preliminary ResultsINTRODUCTION: Maximum oxygen uptake (VO2max) is maintained during space flight lasting <15 d, but has not been measured during long-duration missions. This abstract describes pre-flight and in-flight preliminary findings from the International Space Station (ISS) VO2max experiment. METHODS: Seven astronauts (4 M, 3 F: 47 +/- 5 yr, 174 +/- 7 cm, 74.1 +/- 14.7 kg [mean +/- SD]) performed cycle exercise tests to volitional maximum approx.45 d before flight and tests were scheduled every 30 d during flight beginning on flight day (FD) 14. Tests consisted of three 5-min stages designed to elicit 25%, 50%, and 75% of preflight VO2max, followed by 25 W/min increases. VO2 and heart rate (HR) were measured using the ISS Portable Pulmonary Function System (PPFS) (Damec, Odense, DK). Unfortunately the PPFS did not arrive at the ISS in time to support early test sessions for 3 crewmembers. Descriptive statistics are presented for pre-flight vs. late-flight (FD 147 +/- 33 d) comparisons for all subjects (n=7); and pre-flight, early (FD 18 +/- 3) and late-flight (FD 156 +/- 5) data are presented for subjects (n=4) who completed all of these test sessions. RESULTS: When all subjects are considered, average VO2max decreased from pre- to late in-flight (2.98 +/- 0.85 vs. 2.57 +/- 0.50 L/min) while maximum HR late-flight seemed unchanged (178 +/- 9 vs. 175 +/- 8 beats/min). Similarly, for subjects who completed pre-, early, and late flight measurements (n=4), mean VO2max declined from 3.19 +/- 0.75 L/min preflight to 2.43 +/- 0.43 and 2.62 +/- 0.38 L/min early and late-flight, respectively. Maximum HR was 183 +/- 8, 174 +/- 8, and 179 +/- 6 beats/min pre-, early- and late-flight. DISCUSSION: Average VO2max declined during flight and did not appreciably recover as flight duration increased; however much inter-subject variation occurred in these changes.
Document ID
20100042138
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Moore, A. D., Jr.
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Evetts, S. N.
(Wyle Labs. GmbH Cologne, Germany)
Feiveson, A.H.
(NASA Johnson Space Center Houston, TX, United States)
Lee, S. M. C.
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
McCleary, F. A.
(Lockheed Martin Corp. United States)
Platts, S. H.
(NASA Johnson Space Center Houston, TX, United States)
Ploutz-Snyder, L.
(Universities Space Research Association United States)
Date Acquired
August 25, 2013
Publication Date
January 1, 2010
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-22349
Meeting Information
Meeting: 18th IAA Humans in Space Symposium: Integration and Cooperation in the Next Golden Age of Human Space Flight
Location: Houston, TX
Country: United States
Start Date: April 11, 2011
End Date: April 15, 2011
Sponsors: International Academy of Astronautics
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available